Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Marker Therapeutics, Inc. has filed 902 SEC EDGAR filings since 03 Sep 1999

SEC filing history

Showing 51-75 of 676 matching filings.

Per page
25
Current page
3
EFFECT File 333-284233

EFFECT filing

Filing date
17 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-284233

424B3

Filing date
17 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284233

UPLOAD filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37939

PRE 14A

Filing date
13 Jan 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-284233

S-3

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-533696

D filing

Filing date
30 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-58217

SCHEDULE 13D/A filing

Filing date
23 Dec 2024
Reporting date
Not listed
Next action
Verify source filing
EFFECT File 333-283512

EFFECT filing

Filing date
06 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283512

424B3

Filing date
06 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283512

UPLOAD filing

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-283512

S-3

Filing date
27 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-58217

NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A

Filing date
17 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .